Format

Send to

Choose Destination
EuroIntervention. 2016 Sep 18;12(Y):Y33-6. doi: 10.4244/EIJV12SYA8.

Late degeneration of transcatheter aortic valves: pathogenesis and management.

Author information

1
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy.

Abstract

There is a growing body of evidence demonstrating the durability of current transcatheter aortic valve implantation (TAVI) devices up to 5 years. However, it is well known that transcatheter aortic valves can degenerate in a manner similar to surgical bioprostheses. In this review we briefly discuss the modes of failure of trans-catheter aortic valves and their potential management.

PMID:
27640028
DOI:
10.4244/EIJV12SYA8
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Europa Digital & Publishing
Loading ...
Support Center